Radial versus femoral and bivalirudin versus unfractionated heparin in vulnerable patients with acute coronary syndromes
Rev Esp Cardiol (Engl Ed). 2020 Nov;73(11):874-876.
doi: 10.1016/j.rec.2020.05.003.
Epub 2020 Jun 6.
[Article in
English,
Spanish]
Affiliations
- 1 Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
- 2 Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida, United States. Electronic address: dominick.angiolillo@jax.ufl.edu.
No abstract available
MeSH terms
-
Acute Coronary Syndrome* / drug therapy
-
Anticoagulants* / therapeutic use
-
Heparin* / therapeutic use
-
Hirudin Therapy*
-
Hirudins
-
Humans
-
Peptide Fragments / therapeutic use*
-
Percutaneous Coronary Intervention
-
Recombinant Proteins / therapeutic use
-
Treatment Outcome
Substances
-
Anticoagulants
-
Hirudins
-
Peptide Fragments
-
Recombinant Proteins
-
Heparin
-
bivalirudin